Systematic review of economic evaluations and cost analyses of guideline implementation strategies

Luke David Vale, Ruth Elizabeth Thomas, Graeme Stewart MacLennan, Jeremy Grimshaw

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

To appraise the quality of economic studies undertaken as part of evaluations of guideline implementation strategies, we conducted a systematic review of such studies published between 1966 and 1998. Studies were assessed against BMJ economic evaluations guidelines for each stage (guideline development, implementation and treatment). Of 235 studies identified, 63 reported some information on cost. Only 3 studies provided evidence that their guideline was effective and efficient, 38 reported treatment costs only, 12 implementation and treatment costs, I I implementation costs alone, and 2 guideline development, implementation and treatment costs. No study gave reasonably complete information on costs. Thus, very few satisfactory economic evaluations of guideline implementation strategies have been performed. Current evaluations have numerous methodological defects and rarely consider all relevant costs and benefits. Future evaluations should focus on evaluating the implementation of evidence-based guidelines.

Original languageEnglish
Pages (from-to)111-121
Number of pages11
JournalEuropean Journal of Health Economics
Volume8
Issue number2
Early online date9 Mar 2007
DOIs
Publication statusPublished - Jun 2007

Keywords

  • cost-effectiveness analysis
  • physician (or health care professional) behaviour
  • practice guidelines
  • quality improvement
  • systematic review
  • clinical-practice guidelines
  • randomized controlled trial
  • quality assurance
  • interventional trial
  • time-series
  • health-care
  • experience
  • therapy
  • program
  • reimbursement

Cite this

Systematic review of economic evaluations and cost analyses of guideline implementation strategies. / Vale, Luke David; Thomas, Ruth Elizabeth; MacLennan, Graeme Stewart; Grimshaw, Jeremy.

In: European Journal of Health Economics, Vol. 8, No. 2, 06.2007, p. 111-121.

Research output: Contribution to journalArticle

@article{d869fe25b2224b0fb5839933e7b472dc,
title = "Systematic review of economic evaluations and cost analyses of guideline implementation strategies",
abstract = "To appraise the quality of economic studies undertaken as part of evaluations of guideline implementation strategies, we conducted a systematic review of such studies published between 1966 and 1998. Studies were assessed against BMJ economic evaluations guidelines for each stage (guideline development, implementation and treatment). Of 235 studies identified, 63 reported some information on cost. Only 3 studies provided evidence that their guideline was effective and efficient, 38 reported treatment costs only, 12 implementation and treatment costs, I I implementation costs alone, and 2 guideline development, implementation and treatment costs. No study gave reasonably complete information on costs. Thus, very few satisfactory economic evaluations of guideline implementation strategies have been performed. Current evaluations have numerous methodological defects and rarely consider all relevant costs and benefits. Future evaluations should focus on evaluating the implementation of evidence-based guidelines.",
keywords = "cost-effectiveness analysis, physician (or health care professional) behaviour, practice guidelines, quality improvement, systematic review, clinical-practice guidelines, randomized controlled trial, quality assurance, interventional trial, time-series, health-care, experience, therapy, program, reimbursement",
author = "Vale, {Luke David} and Thomas, {Ruth Elizabeth} and MacLennan, {Graeme Stewart} and Jeremy Grimshaw",
note = "The original publication is available at www.springerlink.com",
year = "2007",
month = "6",
doi = "10.1007/s10198-007-0043-8",
language = "English",
volume = "8",
pages = "111--121",
journal = "European Journal of Health Economics",
issn = "1618-7598",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Systematic review of economic evaluations and cost analyses of guideline implementation strategies

AU - Vale, Luke David

AU - Thomas, Ruth Elizabeth

AU - MacLennan, Graeme Stewart

AU - Grimshaw, Jeremy

N1 - The original publication is available at www.springerlink.com

PY - 2007/6

Y1 - 2007/6

N2 - To appraise the quality of economic studies undertaken as part of evaluations of guideline implementation strategies, we conducted a systematic review of such studies published between 1966 and 1998. Studies were assessed against BMJ economic evaluations guidelines for each stage (guideline development, implementation and treatment). Of 235 studies identified, 63 reported some information on cost. Only 3 studies provided evidence that their guideline was effective and efficient, 38 reported treatment costs only, 12 implementation and treatment costs, I I implementation costs alone, and 2 guideline development, implementation and treatment costs. No study gave reasonably complete information on costs. Thus, very few satisfactory economic evaluations of guideline implementation strategies have been performed. Current evaluations have numerous methodological defects and rarely consider all relevant costs and benefits. Future evaluations should focus on evaluating the implementation of evidence-based guidelines.

AB - To appraise the quality of economic studies undertaken as part of evaluations of guideline implementation strategies, we conducted a systematic review of such studies published between 1966 and 1998. Studies were assessed against BMJ economic evaluations guidelines for each stage (guideline development, implementation and treatment). Of 235 studies identified, 63 reported some information on cost. Only 3 studies provided evidence that their guideline was effective and efficient, 38 reported treatment costs only, 12 implementation and treatment costs, I I implementation costs alone, and 2 guideline development, implementation and treatment costs. No study gave reasonably complete information on costs. Thus, very few satisfactory economic evaluations of guideline implementation strategies have been performed. Current evaluations have numerous methodological defects and rarely consider all relevant costs and benefits. Future evaluations should focus on evaluating the implementation of evidence-based guidelines.

KW - cost-effectiveness analysis

KW - physician (or health care professional) behaviour

KW - practice guidelines

KW - quality improvement

KW - systematic review

KW - clinical-practice guidelines

KW - randomized controlled trial

KW - quality assurance

KW - interventional trial

KW - time-series

KW - health-care

KW - experience

KW - therapy

KW - program

KW - reimbursement

U2 - 10.1007/s10198-007-0043-8

DO - 10.1007/s10198-007-0043-8

M3 - Article

VL - 8

SP - 111

EP - 121

JO - European Journal of Health Economics

JF - European Journal of Health Economics

SN - 1618-7598

IS - 2

ER -